Loading...
 
Translate Register Log In Login with facebookLogin and Register

Multiple Sclerosis and Omega-3 – eight studies as of Aug 2019

Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review

Nutritional Neuroscience https://doi.org/10.1080/1028415X.2019.1659560
Welayah Ali AlAmmar, Fatima Hassan Albeesh, Layla Makki Ibrahim, Yasmin Yussuf Algindan, Lamya Zohair Yamani & Rabie Yousif Khattab

VitaminDWiki

Items in both categories Multiple Sclerosis and Omega-3 are listed here:


MS updates from Brazil


Overview MS and vitamin D contains the following summary

Clinical interventions have shown that Vitamin D can prevent, treat, and even cure Multiple Sclerosis, at a tiny fraction of the cost of the drugs now used to treat it, and without side effects.

Summary: lack of consensus on how much to prevent, treat, or cure MS.

  • How much Vitamin D to prevent many diseases - such as MS
  • How much Vitamin D is needed to treat MS? There is currently no agreement
       The recommendations range from 40 to 100 ng - which can result of a dose ranging from 3,000 to 20,000 IU/day
  • How Vitamin D is needed to Cure MS?: It appears that 20,000-140,000 IU daily may be needed to CURE the disease
       You must be under the supervision of a doctor who knows what to watch for in your individual situation.
       High doses of Vitamin D cannot be used as a monotherapy.
       You will need to adjust the cofactors: Typically increasing Magnesium and Vitamin K2, and reducing Calcium intake.
       Your doctor will monitor these and might increase your intake of Vitamins B2, C, as well as Omega-3

 Download the PDF from Sci-Hub via VitaminDWiki

Background: Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system, resulting in the degradation of the myelin sheath. Diet especially fish oils and omega-3 has been found to play an important role in MS. This work aimed to review the literature systematically for evidence on the effect of omega-3 fatty acids (EPA, DPA and DHA) on MS progression in adults.

Methods: The literature search was conducted in PubMed, Oxford, Cochrane, Embase, International pharmaceutical abstract, PsychINFO, and clinical trials government. The inclusions were studies performed on humans both male and female, aged 18 years at minimum, diagnosed with MS according to McDonald 2010 criteria. Otherwise, all studies were excluded.

Results: A total of 5554 studies were screened and seven were thoroughly focused on as they typically met the inclusion criteria. These studies showed the beneficial roles of fish oil supplementation and omega-3 fatty acids in improving the quality of life of MS patients. These roles were attributed to their beneficial effects on inflammatory markers, glutathione reductase, reducing the relapsing rate, and achieving balanced omega-6 to omega-3 ratios.

Conclusion: Omega-3 and fish oils supplementations have beneficial effects on reducing the relapsing rate, inflammatory markers, and improving the quality of life for MS patients.

Attached files

ID Name Comment Uploaded Size Downloads
12574 MS Omega-3.pdf PDF 2019 admin 03 Sep, 2019 10:11 739.26 Kb 29
See any problem with this page? Report it (FINALLY WORKS)